Day: 31 July 2024

Araclon Biotech joins Arahealth as a “collaborating partner” within the agreement we reached with Arabiotech in 2023. It has consolidated its position as a pioneering company in the development of projects in the diagnosis and treatment of Alzheimer’s disease and since 2012 it has had the participation of the multinational Grifols in its shareholding.